Completed NA INTERVENTIONAL 8-arm NCT03719248

Thoracic Epidural Reduces Risks of Increased Left Ventricular Mass Index During Coronary Artery Bypass Graft Surgery

High Thoracic Epidural Reduces Risks of Increased Left Ventricular Mass Index and Coronary Vascular Disease During Aortic Valve Replacement Alone or in Addition to Coronary Artery Bypass Graft Surgery

Sponsor: Ahmed Said Elgebaly,MD

Conditions Ischemia Coronary Artery Origin

Interventions thoracic epidural

Updated 4 times since 2018 Last updated: Oct 22, 2018 Started: Jan 1, 2017 Primary completion: Jan 1, 2018 Completion: Jan 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Ischemia Coronary Artery Origin, this trial is completed. The trial is conducted by Ahmed Said Elgebaly,MD and has accumulated 4 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ahmed Said Elgebaly,MD
Tanta University

Data source: Tanta University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tanta, Egypt